APP and epilepsy: The same group [40], in 2014, evaluated the CSF levels of different isoforms of β-amyloid (Aβ peptides: Abx-38, Abx-40, Abx-42, and Ab1-42), soluble APP fragments (sAPP-α/β), t-TAU, p-TAU, and heart-type fatty acid binding protein (H-FABP) in patients with epilepsy, including four with non-convulsive SE.